|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net earnings (loss) | |||||
| Adjustments to reconcile net earnings (loss) to cash from operating activities: | |||||
| Investment Income, Dividend | |||||
| Other Asset Impairment Charges | |||||
| Goodwill, Impairment Loss | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Non-cash interest expense and amortization of debt issuance costs | |||||
| Restructuring Costs | |||||
| Gain (Loss) on Disposition of Intangible Assets | |||||
| Gain (Loss) on Disposition of Business | |||||
| Gain (Loss) on Disposition of Property Plant Equipment | |||||
| Other, net | |||||
| Changes in assets and liabilities (excluding effects of foreign exchange): | |||||
| Receivables, net | |||||
| Inventories | |||||
| Prepaid and other current assets | |||||
| Accounts payable | |||||
| Accrued compensation and employee benefits | |||||
| Other accrued expenses | |||||
| Accrued taxes | |||||
| Other non-current assets and non-current liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Proceeds from CMM Sale Seller Loan Repayment | |||||
| Proceeds from Sale of Intangible Assets | |||||
| Acquisitions of business (net of cash acquired) | |||||
| Payments to Acquire Assets, Investing Activities | |||||
| Additions to property, plant, and equipment | |||||
| Proceeds from the sale of property, plant, and equipment | |||||
| Payments for (Proceeds from) Investments | |||||
| Proceeds from Sale of Short-term Investments | |||||
| Net cash (used in) provided by investing activities | |||||
| Financing Activities | |||||
| Payments under revolving credit facility | |||||
| Debt instrument, face amount | |||||
| Payments Under CD Seller Note | |||||
| Borrowings under revolving credit facility | |||||
| Payments for Repurchase of Common Stock | |||||
| Payments of debt issuance costs | |||||
| Proceeds from Stock Options Exercised | |||||
| Tax on restricted and performance stock unit vesting and stock option exercises | |||||
| Payments of finance lease obligations | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | |||||
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total | |||||
| Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations | |||||
| Supplemental information - cash paid during the year for: | |||||
| Income taxes | |||||
| Interest | |||||
Loading...